ASO Author Reflections: Minimally Invasive Surgical Staging in Endometrial Cancer Diagnosed After Supracervical Hysterectomy - The Role of Cervical Injection to Detect Sentinel Lymph Node with Indocyanine Green-Reference-Cited by-同舟云学术

ASO Author Reflections: Minimally Invasive Surgical Staging in Endometrial Cancer Diagnosed After Supracervical Hysterectomy - The Role of Cervical Injection to Detect Sentinel Lymph Node with Indocyanine Green

Published:2021-08-23 Issue:1 Volume:29 Page:684-685
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Bizzarri Nicolò^ORCID,Rosati Andrea,Scambia Giovanni,Fanfani Francesco

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10694-8.pdf

Reference6 articles.

1. Buda A, Marco C, Dolci C, et al. Sentinel node mapping in high risk endometrial cancer after laparoscopic supracervical hysterectomy with morcellation. Int J Surg Case Rep. 2013;4(10):809–12. https://doi.org/10.1016/j.ijscr.2013.06.010.

2. Bizzarri N, Rosati A, Scambia G, Fanfani F. Sentinel lymph node mapping in endometrial cancer after supracervical hysterectomy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10559-0.

3. Epstein E, Fischerova D, Valentin L, et al. Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study [published correction appears in Ultrasound Obstet Gynecol. 2018 Nov;52(5):684]. Ultrasound Obstet Gynecol. 2018;51(6):818-828. https://doi.org/10.1002/uog.18909

4. Ercoli A, Delmas V, Iannone V, et al. The lymphatic drainage of the uterine cervix in adult fresh cadavers: anatomy and surgical implications. Eur J Surg Oncol. 2010;36(3):298–303. https://doi.org/10.1016/j.ejso.2009.06.009.

5. Ditto A, Casarin J, Pinelli C, et al. Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: a multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group [published correction appears in Eur J Cancer. 2021 Feb; 144:399]. Eur J Cancer. 2020;140:1–10.